FMTVDM©℗ provides first patented quantitative method to accurately measure both heart disease and breast cancer on the “Health-Spectrum”

Main Article Content

Richard M Fleming*
Matthew R Fleming
Tapan K Chaudhuri
Andrew McKusick

Downloads

Download data is not yet available.

Article Details

Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., & McKusick, A. (2019). FMTVDM©℗ provides first patented quantitative method to accurately measure both heart disease and breast cancer on the “Health-Spectrum”. Journal of Cardiovascular Medicine and Cardiology, 6(2), 019–020. https://doi.org/10.17352/2455-2976.000084
Review Article(s)

Copyright (c) 2019 Fleming RM, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Sheikine Y, Berman DS, DiCarli F (2010) Technetium-99m-sestamibi redistribution after exercise stress test identified by a novel cardiac gamma camera: Two case reports. Clin. Cardiol 33: E39-45. Link: https://bit.ly/2WSj6yh

Fleming RM, Chaudhuri TK, McKusick A (2019) The FDA, HHS, Sestamibi Redistribution and Quantification. AS Pharm Sci 3: 47-69. Link: https://bit.ly/2L4u4db

Won KS, Jo II, Kim SH (2012) Five-minutes post-stress gated myocardial perfusion SPECT using Tc-99m tetrofosmin. J Nucl Med 53: 1831. Link: https://bit.ly/2IRaT3O

Grady D, Chaput L, Kristof M (2003) Diagnosis and treatment of coronary heart disease in women: Systematic review of evidence on selected topics. Evidence report/technology assessment Number 81. (Prepared by the University of California, San Francisco-Stanford evidence-based practice center under Contract No. 290-97-0013.) AHRQ Publication No. 03-E037. Rockville, MD: Agency for Healthcare Research and Quality. Link: www.ahrq.gov

Bruening W, Launders J, Pinkney N, Kostinsky H, Schoelles K, et al. (2006) Comparative Effectiveness Review. Number 2: Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities. (Prepared for the Agency for Healthcare Research and Quality, U.S. Dept of Health and Human Services). AHRQ Publication No. 06-EHC005-EF. Link: www.ahrq.gov